{"entity":{"type":"insider","cik":"0001298079","url":"/insider/0001298079","json_url":"/insider/0001298079.json","name":"Brazzell Romulus K","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":13,"n_filings":13,"first":"2021-06-29","last":"2025-10-24","span_basis":"filed_date"},"name_variants":[{"name":"Brazzell Romulus K","source":"filing","n_filings":13,"first_seen":"2021-06-29","last_seen":"2025-10-24"}],"transactions":[{"id":4914553,"accession":"0001298079-25-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001298079-25-000003","line_url":"/filing/0001298079-25-000003#line-1","is_derivative":false,"issuer_cik":"0001298079","issuer_name":"KALA BIO, Inc.","issuer_ticker":"KALA","issuer_name_source":null,"issuer_url":"/issuer/0001298079","owner_cik":"0001298079","owner_name":"Brazzell Romulus K","owner_display_name":"Brazzell Romulus K","owner_url":"/insider/0001298079","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SEE REMARKS","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":46748.0,"shares_display":"46,748","price_per_share":0.83,"price_display":"0.83","price_state":"stated","total_value":38800.84,"total_display":"38,800.84","total_whole":"38,801","shares_owned_after":35952.0,"shares_owned_after_display":"35,952","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-22","filed_date":"2025-10-24","scope":"insider"},{"id":4589911,"accession":"0001415889-25-018318","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-018318","line_url":"/filing/0001415889-25-018318#line-1","is_derivative":false,"issuer_cik":"0001298079","issuer_name":"KALA BIO, Inc.","issuer_ticker":"KALA","issuer_name_source":null,"issuer_url":"/issuer/0001298079","owner_cik":"0001298079","owner_name":"Brazzell Romulus K","owner_display_name":"Brazzell Romulus K","owner_url":"/insider/0001298079","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SEE REMARKS","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5251.0,"shares_display":"5,251","price_per_share":4.01,"price_display":"4.01","price_state":"stated","total_value":21056.51,"total_display":"21,056.51","total_whole":"21,057","shares_owned_after":82698.0,"shares_owned_after_display":"82,698","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-24","filed_date":"2025-06-26","scope":"insider"},{"id":4770513,"accession":"0001415889-25-015678","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-015678","line_url":"/filing/0001415889-25-015678#line-1","is_derivative":false,"issuer_cik":"0001298079","issuer_name":"KALA BIO, Inc.","issuer_ticker":"KALA","issuer_name_source":null,"issuer_url":"/issuer/0001298079","owner_cik":"0001298079","owner_name":"Brazzell Romulus K","owner_display_name":"Brazzell Romulus K","owner_url":"/insider/0001298079","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SEE REMARKS","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3687.0,"shares_display":"3,687","price_per_share":3.74,"price_display":"3.74","price_state":"stated","total_value":13789.38,"total_display":"13,789.38","total_whole":"13,789","shares_owned_after":87949.0,"shares_owned_after_display":"87,949","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-06-03","filed_date":"2025-06-04","scope":"insider"},{"id":5037789,"accession":"0001415889-25-001061","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-25-001061","line_url":"/filing/0001415889-25-001061#line-2","is_derivative":false,"issuer_cik":"0001298079","issuer_name":"KALA BIO, Inc.","issuer_ticker":"KALA","issuer_name_source":null,"issuer_url":"/issuer/0001298079","owner_cik":"0001298079","owner_name":"Brazzell Romulus K","owner_display_name":"Brazzell Romulus K","owner_url":"/insider/0001298079","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SEE REMARKS","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2446.0,"shares_display":"2,446","price_per_share":7.63,"price_display":"7.63","price_state":"stated","total_value":18662.98,"total_display":"18,662.98","total_whole":"18,663","shares_owned_after":92418.0,"shares_owned_after_display":"92,418","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-06","filed_date":"2025-01-07","scope":"insider"},{"id":2661485,"accession":"0001415889-24-018373","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-018373","line_url":"/filing/0001415889-24-018373#line-1","is_derivative":false,"issuer_cik":"0001298079","issuer_name":"KALA BIO, Inc.","issuer_ticker":"KALA","issuer_name_source":null,"issuer_url":"/issuer/0001298079","owner_cik":"0001298079","owner_name":"Brazzell Romulus K","owner_display_name":"Brazzell Romulus K","owner_url":"/insider/0001298079","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SEE REMARKS","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5489.0,"shares_display":"5,489","price_per_share":4.75,"price_display":"4.75","price_state":"stated","total_value":26072.75,"total_display":"26,072.75","total_whole":"26,073","shares_owned_after":83982.0,"shares_owned_after_display":"83,982","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-26","filed_date":"2024-06-27","scope":"insider"},{"id":2755432,"accession":"0001415889-24-015223","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-015223","line_url":"/filing/0001415889-24-015223#line-1","is_derivative":false,"issuer_cik":"0001298079","issuer_name":"KALA BIO, Inc.","issuer_ticker":"KALA","issuer_name_source":null,"issuer_url":"/issuer/0001298079","owner_cik":"0001298079","owner_name":"Brazzell Romulus K","owner_display_name":"Brazzell Romulus K","owner_url":"/insider/0001298079","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SEE REMARKS","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2002.0,"shares_display":"2,002","price_per_share":6.09,"price_display":"6.09","price_state":"stated","total_value":12192.18,"total_display":"12,192.18","total_whole":"12,192","shares_owned_after":89471.0,"shares_owned_after_display":"89,471","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-31","filed_date":"2024-06-03","scope":"insider"},{"id":2483450,"accession":"0001415889-24-000770","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-000770","line_url":"/filing/0001415889-24-000770#line-2","is_derivative":false,"issuer_cik":"0001298079","issuer_name":"KALA BIO, Inc.","issuer_ticker":"KALA","issuer_name_source":null,"issuer_url":"/issuer/0001298079","owner_cik":"0001298079","owner_name":"Brazzell Romulus K","owner_display_name":"Brazzell Romulus K","owner_url":"/insider/0001298079","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SEE REMARKS","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1617.0,"shares_display":"1,617","price_per_share":6.74,"price_display":"6.74","price_state":"stated","total_value":10898.58,"total_display":"10,898.58","total_whole":"10,899","shares_owned_after":91473.0,"shares_owned_after_display":"91,473","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-04","filed_date":"2024-01-05","scope":"insider"},{"id":8560732,"accession":"0001415889-23-000638","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-23-000638","line_url":"/filing/0001415889-23-000638#line-2","is_derivative":false,"issuer_cik":"0001298079","issuer_name":"Kala Pharmaceuticals, Inc.","issuer_ticker":"KALA","issuer_name_source":null,"issuer_url":"/issuer/0001298079","owner_cik":"0001298079","owner_name":"Brazzell Romulus K","owner_display_name":"Brazzell Romulus K","owner_url":"/insider/0001298079","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SEE REMARKS","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":73.0,"shares_display":"73","price_per_share":28.53,"price_display":"28.53","price_state":"stated","total_value":2082.69,"total_display":"2,082.69","total_whole":"2,083","shares_owned_after":18536.0,"shares_owned_after_display":"18,536","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-04","filed_date":"2023-01-06","scope":"insider"},{"id":6222388,"accession":"0001415889-22-010879","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-22-010879","line_url":"/filing/0001415889-22-010879#line-1","is_derivative":false,"issuer_cik":"0001298079","issuer_name":"Kala Pharmaceuticals, Inc.","issuer_ticker":"KALA","issuer_name_source":null,"issuer_url":"/issuer/0001298079","owner_cik":"0001298079","owner_name":"Brazzell Romulus K","owner_display_name":"Brazzell Romulus K","owner_url":"/insider/0001298079","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SEE REMARKS","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":261.0,"shares_display":"261","price_per_share":6.51,"price_display":"6.51","price_state":"stated","total_value":1699.11,"total_display":"1,699.11","total_whole":"1,699","shares_owned_after":5809.0,"shares_owned_after_display":"5,809","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-26","filed_date":"2022-10-28","scope":"insider"},{"id":6934493,"accession":"0001415889-22-007061","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-22-007061","line_url":"/filing/0001415889-22-007061#line-1","is_derivative":false,"issuer_cik":"0001298079","issuer_name":"Kala Pharmaceuticals, Inc.","issuer_ticker":"KALA","issuer_name_source":null,"issuer_url":"/issuer/0001298079","owner_cik":"0001298079","owner_name":"Brazzell Romulus K","owner_display_name":"Brazzell Romulus K","owner_url":"/insider/0001298079","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SEE REMARKS","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3144.0,"shares_display":"3,144","price_per_share":0.37,"price_display":"0.37","price_state":"stated","total_value":1163.28,"total_display":"1,163.28","total_whole":"1,163","shares_owned_after":285201.0,"shares_owned_after_display":"285,201","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-06-27","filed_date":"2022-06-29","scope":"insider"},{"id":6244035,"accession":"0001415889-22-000404","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-22-000404","line_url":"/filing/0001415889-22-000404#line-1","is_derivative":false,"issuer_cik":"0001298079","issuer_name":"Kala Pharmaceuticals, Inc.","issuer_ticker":"KALA","issuer_name_source":null,"issuer_url":"/issuer/0001298079","owner_cik":"0001298079","owner_name":"Brazzell Romulus K","owner_display_name":"Brazzell Romulus K","owner_url":"/insider/0001298079","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SEE REMARKS","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3504.0,"shares_display":"3,504","price_per_share":1.3,"price_display":"1.30","price_state":"stated","total_value":4555.2,"total_display":"4,555.20","total_whole":"4,555","shares_owned_after":288345.0,"shares_owned_after_display":"288,345","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-04","filed_date":"2022-01-05","scope":"insider"},{"id":4643058,"accession":"0001415889-21-005010","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-21-005010","line_url":"/filing/0001415889-21-005010#line-1","is_derivative":false,"issuer_cik":"0001298079","issuer_name":"Kala Pharmaceuticals, Inc.","issuer_ticker":"KALA","issuer_name_source":null,"issuer_url":"/issuer/0001298079","owner_cik":"0001298079","owner_name":"Brazzell Romulus K","owner_display_name":"Brazzell Romulus K","owner_url":"/insider/0001298079","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12757.0,"shares_display":"12,757","price_per_share":1.8,"price_display":"1.80","price_state":"stated","total_value":22962.6,"total_display":"22,962.60","total_whole":"22,963","shares_owned_after":291849.0,"shares_owned_after_display":"291,849","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-26","filed_date":"2021-10-28","scope":"insider"},{"id":4250635,"accession":"0001415889-21-003258","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-21-003258","line_url":"/filing/0001415889-21-003258#line-1","is_derivative":false,"issuer_cik":"0001298079","issuer_name":"Kala Pharmaceuticals, Inc.","issuer_ticker":"KALA","issuer_name_source":null,"issuer_url":"/issuer/0001298079","owner_cik":"0001298079","owner_name":"Brazzell Romulus K","owner_display_name":"Brazzell Romulus K","owner_url":"/insider/0001298079","role":"Officer (CHIEF MEDICAL OFFICER)","role_mark":"O","role_mark_label":"Officer (CHIEF MEDICAL OFFICER)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CHIEF MEDICAL OFFICER","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3034.0,"shares_display":"3,034","price_per_share":5.77,"price_display":"5.77","price_state":"stated","total_value":17506.18,"total_display":"17,506.18","total_whole":"17,506","shares_owned_after":300962.0,"shares_owned_after_display":"300,962","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-28","filed_date":"2021-06-29","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":13,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":13,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":13},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001479419","name":"KALA BIO, Inc.","url":"/issuer/0001479419","role":"Officer","n_filings":13,"first_seen":"2021-06-29","last_seen":"2025-10-24"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001298079","retrieved_at":"2026-08-24T10:12:06+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}